Effects of Fenofibric Acid on Diabetic Macular Edema: The MacuFen study

Fenofibrate: A New Treatment for Diabetic Retinopathy. Molecular Mechanisms and Future Perspectives

(2013) Rafael Simo et al.   CURRENT MEDICINAL CHEMISTRY

Current Epidemiology of Diabetic Retinopathy and Diabetic Macular Edema

(2012) Jie Ding et al.   Current Diabetes Reports

Emerging Pharmacotherapies for Diabetic Macular Edema

(2012) Golnaz Javey et al.   Experimental Diabetes Research

New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel

(2012) F Bandello et al.   EYE

Fibrates and Statins in the Treatment of Diabetic Retinopathy

(2011) Jean-Claude Ansquer et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation

(2011) M. Villarroel et al.   DIABETOLOGIA

ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN

(2011) Lloyd Paul Aiello et al.   RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES

Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study): A 12-month, randomized, controlled, double-masked, multicenter phase II study

(2010) P. Massin et al.   DIABETES CARE

Diabetic retinopathy

(2010) Ning Cheung et al.   LANCET

Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

(2010) Quan Dong Nguyen et al.   OPHTHALMOLOGY

Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema

(2010) Michael J. Elman et al.   OPHTHALMOLOGY

Advances in the Medical Treatment of Diabetic Retinopathy

(2009) R. Simo et al.   DIABETES CARE